@article{1c5f56c3642f4f9c9a59d86f74d335b6,
title = "Treatment of hospital-acquired pneumonia",
author = "Niederman, {Michael S.} and Craven, {Donal E.} and Jean Chastre and Kollef, {Marin H.} and Luna, {Carlos M.} and Antonio Torres and Wunderink, {Richard G.}",
note = "Funding Information: All of the authors were members of the 2005 ATS-IDSA guideline committee. MSN has been a speaker for Merck and Pfizer, a consultant for Pfizer, Meiji, Merck, Bayer, Novartis, and Glaxo Smith Kline, and has received research support from Bayer and Novartis. DEC has received honoraria from Pfizer, Cubist, Merck, Sanofi-Pasteur, and Covidien, and has received grant support from Pfizer. JC has received consultancy or lecture fees from Nektar-Bayer, Pfizer, Brahms, Janssen-Citag, Kalobios-Sanofi, and Astellas. MHK has been a speaker for Cubist, Hospira, and Merck and a consultant for Cubist, Merck, and Meiji. CML has been a consultant or lecturer for Pfizer, Bayer, Merck, and AstraZeneca, and has received research support from Pfizer. AT has received research grants from Astellas and Pfizer and has been a consultant for Astellas. RGW has been a consultant for Trius, Pfizer, Crucell, Bayer, Novartis, Eisai, Glaxo Smith Kline, AstraZeneca, bioM{\'e}rieux, Meiji Seika, Sanofi, and Achaogen, has received grant support from bioM{\'e}rieux, National Institutes of Health-National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, Pfizer, Braun, Sanofi-Pasteur, and Altor, and has received honoraria from Pfizer.",
year = "2011",
month = oct,
doi = "10.1016/S1473-3099(11)70260-2",
language = "English (US)",
volume = "11",
pages = "728",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "10",
}
